Literature DB >> 9890432

Ca2+ and Mg2+ selectively induce aggregates of PHF-tau but not normal human tau.

L S Yang1, H Ksiezak-Reding.   

Abstract

The molecular mechanism of pathological aggregation of microtubule-associated protein tau during neurodegeneration is unclear. In the present study, the in vitro effect of various metal ions on the aggregation of tau was examined using paired helical filament tau (PHF-tau) obtained from corticobasal degeneration (CBD) and Alzheimer's disease (AD) brains as well as normal human tau proteins isolated from fetal and adult brains and a recombinant system. Among the metal ions tested, Ca2+ and Mg2+ effectively induced formation of approximately 340 kD aggregates of PHF-tau but not normal tau proteins as determined by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and immunoblotting. Al3+ and Fe2+ precipitated both PHF-tau and normal tau protein as SDS-insoluble pellets. The other metal ions examined (Cu2+, Zn2+, and Li+) were inactive and caused neither aggregation nor precipitation of any tau protein. Intermixing experiments using PHF-tau and various normal tau preparations showed that the 340-kD aggregates induced by Ca2+ contained PHF-tau but not normal tau regardless whether unmodified (recombinant) or highly phosphorylated (fetal brain) tau proteins were used. The present results suggest that post-translational modifications other than the fetal-type phosphorylation are required for Ca2+- and Mg2+-dependent aggregation of PHF-tau and that the regional elevation of these ions may trigger pathological deposition of PHF-tau in certain neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9890432     DOI: 10.1002/(SICI)1097-4547(19990101)55:1<36::AID-JNR5>3.0.CO;2-E

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

Review 1.  Naturally Occurring Antioxidant Therapy in Alzheimer's Disease.

Authors:  Andrila E Collins; Tarek M Saleh; Bettina E Kalisch
Journal:  Antioxidants (Basel)       Date:  2022-01-23

2.  Low micromolar zinc accelerates the fibrillization of human tau via bridging of Cys-291 and Cys-322.

Authors:  Zhong-Ying Mo; Ying-Zhu Zhu; Hai-Li Zhu; Jun-Bao Fan; Jie Chen; Yi Liang
Journal:  J Biol Chem       Date:  2009-10-13       Impact factor: 5.157

3.  Synergistic influence of phosphorylation and metal ions on tau oligomer formation and coaggregation with α-synuclein at the single molecule level.

Authors:  Georg Nübling; Benedikt Bader; Johannes Levin; Jenna Hildebrandt; Hans Kretzschmar; Armin Giese
Journal:  Mol Neurodegener       Date:  2012-07-23       Impact factor: 14.195

4.  Clues to neuro-degeneration in Niemann-Pick type C disease from global gene expression profiling.

Authors:  Jonathan V Reddy; Ian G Ganley; Suzanne R Pfeffer
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

Review 5.  Metal Ion Effects on Aβ and Tau Aggregation.

Authors:  Anne Claire Kim; Sungsu Lim; Yun Kyung Kim
Journal:  Int J Mol Sci       Date:  2018-01-02       Impact factor: 5.923

Review 6.  Exposure of metal toxicity in Alzheimer's disease: An extensive review.

Authors:  Fahadul Islam; Sheikh Shohag; Shomaya Akhter; Md Rezaul Islam; Sharifa Sultana; Saikat Mitra; Deepak Chandran; Mayeen Uddin Khandaker; Ghulam Md Ashraf; Abubakr M Idris; Talha Bin Emran; Simona Cavalu
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

Review 7.  Biometal Dyshomeostasis and Toxic Metal Accumulations in the Development of Alzheimer's Disease.

Authors:  Yong Li; Qian Jiao; Huamin Xu; Xixun Du; Limin Shi; Fengju Jia; Hong Jiang
Journal:  Front Mol Neurosci       Date:  2017-10-24       Impact factor: 5.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.